Location History:
- Taipei, TW (2014)
- Zhubei, TW (2023)
Company Filing History:
Years Active: 2014-2023
Title: The Innovations of Ming-Hua Yang
Introduction
Ming-Hua Yang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid detection methods and antibodies. With a total of 3 patents to his name, Yang continues to push the boundaries of scientific research and innovation.
Latest Patents
One of Yang's latest patents is a nucleic acid detection kit and method. This kit includes a primer set specifically designed for detecting GAPDH nucleic acid. The primer set consists of a forward inner primer, a forward outer primer, a backward inner primer, and a backward outer primer, all tailored for GAPDH nucleic acids. This innovative primer set is utilized in a loop-mediated isothermal amplification (LAMP) process, enhancing the efficiency of nucleic acid detection. Another notable patent is for an anti-human epidermal growth factor receptor (EGFR) antibody. This antibody features an amino acid sequence as set forth in SEQ ID No. 3 and is designed to bind to a labeling agent for cell labeling purposes. Additionally, Yang has developed a novel method for screening anti-EGFR antibodies, showcasing his expertise in antibody technology.
Career Highlights
Ming-Hua Yang is affiliated with the Industrial Technology Research Institute, where he collaborates with other leading researchers in the field. His work has not only advanced scientific knowledge but has also contributed to practical applications in medical diagnostics and therapeutics.
Collaborations
Yang has worked alongside notable colleagues such as Min-Yuan Chou and Hsiang-Ching Wang. Their collaborative efforts have further enriched the research environment and fostered innovation within their projects.
Conclusion
Ming-Hua Yang's contributions to biotechnology through his patents and collaborative work highlight his role as a key innovator in the field. His advancements in nucleic acid detection and antibody technology continue to pave the way for future research and applications.